EP3317385B1 - Procédé de préparation de 2-monoacylglycérides - Google Patents

Procédé de préparation de 2-monoacylglycérides Download PDF

Info

Publication number
EP3317385B1
EP3317385B1 EP16739318.0A EP16739318A EP3317385B1 EP 3317385 B1 EP3317385 B1 EP 3317385B1 EP 16739318 A EP16739318 A EP 16739318A EP 3317385 B1 EP3317385 B1 EP 3317385B1
Authority
EP
European Patent Office
Prior art keywords
monoacylglyceride
acid
fatty acid
lipase
acetal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP16739318.0A
Other languages
German (de)
English (en)
Other versions
EP3317385A1 (fr
Inventor
Joseph C. Rongione
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stepan Co
Original Assignee
Stepan Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stepan Co filed Critical Stepan Co
Publication of EP3317385A1 publication Critical patent/EP3317385A1/fr
Application granted granted Critical
Publication of EP3317385B1 publication Critical patent/EP3317385B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C1/00—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids
    • C11C1/02—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids from fats or fatty oils
    • C11C1/04—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids from fats or fatty oils by hydrolysis
    • C11C1/045—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids from fats or fatty oils by hydrolysis using enzymes or microorganisms, living or dead
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C1/00—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids
    • C11C1/08—Refining
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C1/00—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids
    • C11C1/08—Refining
    • C11C1/10—Refining by distillation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/02—Monohydroxylic acyclic alcohols
    • C07C31/08—Ethanol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/54—Benzaldehyde
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/548—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings having unsaturation outside the six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C07C47/58—Vanillin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003—Triacylglycerol lipase (3.1.1.3)

Definitions

  • the invention relates to protected 2-monoacylglyceride compositions and methods for their preparation and purification.
  • Fatty acid distribution in triglycerides influences absorption, distribution, and tissue uptake (see, e.g., Mu et al., Prog. Lipid Res. 43 (2004) 105 ).
  • Fish oil is a natural source of polyunsaturated fatty acids (PUFA) such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA).
  • PUFA polyunsaturated fatty acids
  • DHA docosahexaenoic acid
  • EPA eicosapentaenoic acid
  • Polyunsaturated fatty acids in fish oil are enriched at the 2- position relative to the overall fatty acid distribution (see, e.g., Irimescu et al. J. Am. Oil Chem. Soc. 78 (2001) 285 ).
  • the synthetic routes employed by Irimescu are typical of known routes that produce symmetrically structured triacylglycerols rich in DHA and EPA with a short- chain fatty acid at the 1- and 3- positions.
  • the methods require two enzymatic steps (cleavage of the 1 - and 3- acyl groups and re-esterification at these sites with ethyl caprylate).
  • the groups on the terminal positions are still fatty acids.
  • the fatty acid content of the delivery system for the polyunsaturated fatty acid would be reduced compared with that of the oil source, as this consideration is important for a reduced-fat diet.
  • Non-fatty acid groups could be used to block the 1 - and 3- positions of glycerol. Yue et al. ( Lipids 41 (2006) 301) showed that the terminal positions of glycerol could be protected with ether linkages, in this case a 1,3-dibenzyl glycerol.
  • the 2- position was esterified with an acyl chloride.
  • the ether protecting groups were removed via hydrogenation.
  • this route has several drawbacks. Synthesis of 1,3-dibenzyl glycerol employs several toxic compounds, notably epichlorohydrin.
  • the esterification with acyl chlorides generates hydrogen chloride, a side product that requires significant engineering controls to manage.
  • catalytic cleavage of the ether linkages takes place under conditions that favor migration of the acyl group from the 2- position to one of the terminal hydroxyl groups.
  • Watanabe et al. (J. Am. Oil Chem. Soc. 91 (2014) 1323 ) describe an enzymatic analysis of positional distribution of fatty acids in solid fat by 1,3-selective transesterification with a lipase. The authors observed, consistent with earlier investigations, that a variety of reaction conditions promote migration of acyl moieties from the 2- position to the 1 - or 3- position.
  • a proton NMR study by Compton et al. J. Am. Oil Chem. Soc. 84 (2007) 343 ) provided dramatic evidence (see Fig. 2, p. 345) of how rapidly an unprotected 2-monoacylglyceride will isomerize to a 1-monoacylglyceride at only 60°C.
  • the invention relates to a method for preparing and purifying a 2-monoacylglyceride acetal or ketal.
  • the method comprises three steps.
  • An unsaturated triglyceride is first reacted with at least two molar equivalents of water, a C 1 -C 8 alcohol, or a mixture thereof in the presence of a lipase at a temperature within the range of 20°C to 80°C for a time sufficient to produce a reaction mixture comprising a 1,3-dihydroxy-2-monoacylglyceride and fatty esters or acids.
  • the 1,3-dihydroxy-2-monoacylglyceride is then reacted with at least one molar equivalent of an aldehyde or ketone, optionally in the presence of an acid catalyst, to produce a mixture comprising a 2-monoacylglyceride acetal or ketal.
  • the fatty esters or acids are removed from the mixture as an overhead product by distillation or wiped-film evaporation to isolate a purified 2-monoacylglyceride acetal or ketal.
  • the 2-monoacylglyceride acetal or ketal is further purified by distillation to separate it from less-volatile impurities.
  • an unsaturated triglyceride is reacted with at least two molar equivalents of a lower alkyl ester or carboxylic acid in the presence of a lipase at a temperature within the range of 20°C to 80°C for a time sufficient to produce a reaction mixture comprising a 1,3-dicarboxy-2-monoacylglyceride and fatty esters or acids. Thereafter, fatty esters or acids are removed from the mixture as an overhead product by distillation or wiped-film evaporation to isolate a purified 1,3-dicarboxy-2-monoacylglyceride.
  • the 1,3-dicarboxy-2-monoacylglyceride is further purified by distillation to separate it from less-volatile impurities.
  • Each method provides a 2-monoacylglyceride protected at the 1- and 3-positions such that the acyl unit remains at the 2- position.
  • Each method provides a product that is enriched in unsaturated fatty acid content when compared with the unsaturated fatty acid content of the original unsaturated triglyceride. The product can therefore provide a desirable unsaturated fatty acid without also delivering additional fatty acid components.
  • Each method utilizes a purification scheme that is practical to implement industrially, thereby avoiding scale-up or toxicity issues of commonly employed purification strategies such as column chromatography, crystallization, or solvent extraction.
  • the invention in a first aspect, relates to a method of preparing and purifying a 2-monoacylglyceride acetal or ketal.
  • the method comprises three steps. First, an unsaturated triglyceride is reacted with water, a C 1 -C 8 alcohol, or a mixture thereof. The reaction is performed in the presence of a lipase under conditions effective to produce a mixture comprising a 1,3-dihydroxy-2-monoacylglyceride and fatty esters or acids.
  • the 1,3-dihydroxy-2-monoacylglyceride is then reacted with at least one molar equivalent of an aldehyde or ketone, optionally in the presence of an acid catalyst, to produce a mixture comprising a 2-monoacylglyceride acetal or ketal.
  • the fatty esters or acids are removed from the mixture as an overhead product by distillation or wiped-film evaporation to isolate a purified 2-monoacylglyceride acetal or ketal.
  • Unsaturated triglycerides suitable for use are well known, and many occur naturally. In general, they are usually oils obtained from vegetable or animal sources. Preferred unsaturated triglycerides have residues of polyunsaturated fatty acids, particularly at the 2- position of the triglyceride.
  • the polyunsaturated fatty acid is an omega-3 or omega-6 polyunsaturated fatty acid.
  • One class of suitable polyunsaturated fatty acids has one or more "methylene-interrupted" polyene units, where two carbon-carbon double bonds are separated by a methylene (-CH 2 -) group, and the carbon-carbon double bonds are primarily or exclusively in a cis-configuration.
  • the omega-3 fatty acids are preferably C 16 to C 24 acids.
  • suitable unsaturated triglycerides can incorporate units from these methylene-interrupted "n3" acids: hexadecatrienoic acid (16:3, “HTA”); alpha-linolenic acid (18:3, “ALA”); stearidonic acid (18:4 "SDA”); eicosatrienoic acid (20:3, “ETE”); eicosatetraenoic acid (20:4, "ETA”); eicosapentaenoic acid (20:5, “EPA”); heneicosapentaenoic acid (21:5, "HPA”); docosapentaenoic acid (22:5, “DPA”); docosahexaenoic acid (22:6, “DHA”); tetracosapentaenoic acid (24:5); and tetracosahexaenoic acid (24:6).
  • Suitable unsaturated triglycerides can incorporate units from these methylene-interrupted "n6" acids: linoleic acid (18:2); gamma-linolenic acid (18:3); eicosadienoic acid (20:2); dihomo-gamma-linolenic acid (20:3); arachidonic acid (20:4, "ARA”); docosadienoic acid (22:2); adrenic acid (22:4); docosapentaenoic acid (22:5); tetracosatetraenoic acid (24:4); and tetracosapentaenoic acid (24:5).
  • Unsaturated triglycerides that incorporate a high proportion of omega-3 unsaturated fatty acids are preferred.
  • Particularly preferred unsaturated triglycerides are fish oils, which tend to be high in polyunsaturated fatty acids, particularly ARA, EPA, and DHA.
  • the unsaturated triglyceride is reacted with at least two molar equivalents of water, a C 1 -C 8 alcohol, or a mixture thereof.
  • Suitable alcohols include methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, tert-butyl alcohol, 1-hexanol, 1-octanol, and the like, and combinations thereof.
  • Ethanol is particularly preferred.
  • a large excess of water or the alcohol can be used.
  • a preferred range is from 2 to 50 molar equivalents, more preferably from 2 to 10 molar equivalents.
  • a lipase preferably a 1,3-specific lipase, which catalyzes conversion of the unsaturated triglyceride to a 1,3-dihydroxy-2-monoacylglyceride.
  • Suitable lipases are conveniently isolated from fungi, yeasts, and other microorganisms.
  • the lipase can be obtained from Candida antarctica, Candida rugosa, Thermomyces lanuginosus, Rhizopus delemar, Rhizomucor miehei, and combinations thereof.
  • Preferred lipases are obtained from Candida antarctica, Thermomyces lanuginosus, and Rhizomucor miehei.
  • a "1,3-specific" lipase can selectively cleave fatty acids from the 1- and 3- positions of a triglyceride while leaving the fatty acid residue at the 2- position intact.
  • Suitable 1,3-specific lipases can be obtained commercially from Novozymes, Sekisui Enzymes, Calzyme Laboratories, and other suppliers. Examples include the Lipozyme® and Novozym® products of Novozymes, such as Lipozyme® TL IM and Lipozyme® RM IM.
  • the amount of lipase needed will depend on the nature of the reactants, the stoichiometry, the actives content and activity of the particular lipase, the reaction conditions, the desired reaction rate, and other factors within the skilled person's discretion. In general, the amount will be within the range of 0.1 to 20 wt.%, more typically 1 to 15 wt.% or 2 to 10 wt.% based on the amount of unsaturated triglyceride.
  • the reaction of the unsaturated triglyceride and water or C 1 -C 8 alcohol is performed at a temperature within the range of 20°C to 80°C, 30°C to 70°C, or 45°C to 60°C.
  • a relatively mild temperature is desirable because more elevated temperatures promote migration of acyl groups from the 2- position to a 1- or 3-position from which a fatty acid residue has been removed.
  • the reaction mixture will comprise a 1,3-dihydroxy-2-monoacylglyceride and fatty esters (if a C 1 -C 8 alcohol is used as the reactant) or fatty acids (if water alone is used as the reactant).
  • the fatty esters or acids will carry through to the next process step.
  • the 1,3-dihydroxy-2-monoacylglyceride produced at this stage is isolated by column chromatography, liquid extraction, or other means.
  • no action is taken to protect against its occurrence, migration of at least some of the 2-monoacyl product to the more thermodynamically stable 1(3)-product begins and continues until the 1(3)-product predominates.
  • the inventive method overcomes this problem of acyl migration from the 2- position by protecting the 1- and 3- positions.
  • the lipase is normally removed from the reaction mixture by decantation, filtration, centrifugation, or other similar means when conversion to the 1,3-dihydroxy-2-monoacylglyceride is shown to be reasonably complete by gas chromatography, thin-layer chromatography, or other suitable analytical methods. Any remaining alcohol or water can be left in the liquid mixture at this stage or it can be partially or completely removed by stripping. In some aspects, the lipase and any water or C 1 -C 8 alcohol are removed from the reaction mixture prior to the second step, preferably at a temperature less than 80°C.
  • the mixture comprising the 1,3-dihydroxy-2-monoacylglyceride and the fatty esters or acids is reacted with at least one molar equivalent of an aldehyde or ketone, optionally in the presence of an acid catalyst, to produce a mixture comprising the fatty esters or acids and a 2-monoacylglyceride acetal or ketal.
  • cyclic, 5- or 6-membered ring acetals or ketals is a known way to protect carbonyl groups, although the reaction has apparently not been utilized to protect 1,3-dihydroxy-2-monoacylglycerides.
  • Glycerol has the ability to form either a 5-membered ring (using adjacent hydroxyl groups) or a 6-membered ring (using hydroxyl groups at the 1- and 3- positions). Although glycerol favors forming the 5-membered ring (see, e.g., Piantadosi et al., J. Am. Chem. Soc. 80 (1958) 6613 ), a 1,3-dihydroxy-2-monoacyl glyceride can only form a 6-membered cyclic acetal or ketal.
  • aldehyde or ketone could be used in theory, readily available, simpler aldehydes and ketones are preferred (e.g., acetaldehyde, butyraldehyde, benzaldehyde, acetone), and food-grade aldehydes and ketones are particularly preferred. Food-grade aldehydes and ketones allow the corresponding acetal or ketal to be supplied "as is" for food products, additives, supplements, and the like.
  • Suitable food-grade aldehydes and ketones include, for example, acetaldehyde, hexanal, octanal, benzaldehyde, cinnamaldehyde, vanillin, ethyl vinyl ketone, 2-furyl methyl ketone, methyl 2-pyrrolyl ketone, watermelon ketone, raspberry ketone, and the like.
  • benzaldehyde, cinnamaldehyde, and vanillin are especially preferred.
  • An acid catalyst is preferably used, although one may not be necessary in all cases, particularly when the reaction product also includes one or more fatty acids.
  • a mineral acid e.g., phosphoric acid
  • an organic acid e.g., acetic acid or p-toluenesulfonic acid
  • Solid acid catalysts e.g., silica-aluminas, organic clays, or sulfonic acid resins such as Amberlyst® resins
  • Amberlyst® resins could also be used.
  • the reaction mixture from the second step comprises the fatty esters or acids generated in the first step and a 2-monoacylglyceride acetal or ketal. Removal of the fatty esters or acids is desirable for providing a product having an enriched content of polyunsaturated fatty acid.
  • polyunsaturated fats will normally have more unsaturation in the fatty acid residue at the 2- position when compared with that of the 1- and 3- positions.
  • the proportion of unsaturated fatty acid residues in the 2-monoacylglyceride acetal or ketal will be increased relative to the proportion of unsaturated fatty acid residues in the unsaturated triglyceride.
  • the equipment and conditions (e.g., temperature, feed rate) used for the distillation or wiped-film evaporation will depend on the particular 2-monoacylglyceride acetal or ketal made, the relative boiling ranges of the fatty esters or acids and the 2-monoacylglyceride acetal or ketal, the required degree of separation, and other factors within the skilled person's discretion.
  • the 2-monoacylglyceride will often be the end product, it may be desirable in some cases to react a purified 2-monoacylglyceride acetal or ketal prepared as described above with water or a C 1 -C 8 alcohol in the presence of a base to produce an enriched unsaturated fatty acid or an enriched C 1 -C 8 alkyl ester of an unsaturated fatty acid. Because these unsaturated fatty acids or esters have unsaturation that originated at the 2- position of an unsaturated triglyceride, usually a polyunsaturated triglyceride, they will often be rich in polyunsaturated content.
  • the invention in another aspect, relates to a method of preparing and purifying a 1,3-dicarboxy-2-monoacylglyceride.
  • the method comprises two steps. First, an unsaturated triglyceride is reacted with at least two molar equivalents of a lower alkyl ester or carboxylic acid in the presence of a lipase at a temperature within the range of 20°C to 80°C for a time sufficient to produce a reaction mixture comprising a 1,3-dicarboxy-2-monoacylglyceride and fatty esters or acids. Thereafter, the fatty esters or acids from the mixture in the first step are removed as an overhead product by distillation or wiped-film evaporation to isolate a purified 1,3-dicarboxy-2-monoacylglyceride.
  • the unsaturated triglyceride is reacted with at least two molar equivalents of a lower alkyl ester or carboxylic acid, preferably a lower alkyl ester.
  • Suitable lower alkyl esters and carboxylic acids have a linear or branched chain of 1 to 10 carbons.
  • the esters are based on linear or branched alcohols having 1 to 8 carbons, preferably 1 to 4 carbons, most preferably methanol or ethanol, especially ethanol.
  • suitable lower alkyl esters include methyl acetate, ethyl acetate, ethyl lactate, ethyl butyrate, ethyl 2-ethylhexanoate, octyl acetate, and the like. Ethyl acetate is preferred.
  • Suitable lower carboxylic acids include acetic acid, propionic acid, butyric acid, hexanoic acid, octanoic acid, 2-ethylhexanoic acid, decanoic acid, and the like. Acetic acid is preferred.
  • the reaction of unsaturated triglyceride and the lower alkyl ester or carboxylic acid is performed at a temperature within the range of 20°C to 80°C, 30°C to 70°C, or 45°C to 60°C. Although less of a concern in this method, relatively mild temperature is desirable here as well to avoid scrambling of the 2-acyl group to either the 1 - or 3-position under the reaction conditions used to form the desired 1,3-dicarboxy-2-monoacylglyceride.
  • the reaction mixture will comprise a 1,3-dicarboxy-2-monoacylglyceride and fatty esters (if a lower alkyl ester is used as the reactant) or fatty acids (if a lower carboxylic acid is used as the reactant).
  • the fatty esters or acids will carry through to the next process step.
  • the proportion of unsaturated fatty acid residues in the 1,3-dicarboxy-2-monoacylglyceride is increased relative to the proportion of unsaturated fatty acid residues in the unsaturated triglyceride.
  • the lipase can be removed from the reaction mixture by decantation, filtration, centrifugation, or other similar means when conversion to the 1,3-dicarboxy-2-monoacylglyceride is shown to be reasonably complete by gas chromatography, thin-layer chromatography, or other suitable analytical methods. Any remaining lower alkyl ester or carboxylic acid can be left in the liquid mixture at this stage or it can be partially or completely removed by stripping. In some aspects, lower alkyl ester or carboxylic acid is removed from the reaction mixture prior to the second step, preferably at a temperature less than 80°C.
  • the equipment and conditions (e.g., temperature, feed rate) used for the distillation or wiped-film evaporation will depend on the particular 1,3-dicarboxy-2-monoacyl glyceride made, the relative boiling ranges of the fatty esters or acids and the 1,3-dicarboxy-2-monoacyl glyceride, the required degree of separation, and other factors within the skilled person's discretion.
  • This allows isolation of a purified 1,3-dicarboxy-2-monoacylglyceride from less-volatile impurities.
  • This could be performed using any of a number of suitable techniques, including use of a short-path still, bulb-to-bulb distillation, wiped-film evaporation with a side draw, or similar techniques that allow recovery of the desired 1,3-dicarboxy-2-monoacylglyceride as an overhead product.
  • the 2-monoacylglyceride will often be the end product, it may be desirable in some cases to react a purified 1,3-dicarboxy-2-monoacylglyceride prepared as described above with water or a C 1 -C 8 alcohol in the presence of a base to produce an enriched unsaturated fatty acid or an enriched C 1 -C 8 alkyl ester of an unsaturated fatty acid. Because these unsaturated fatty acids or esters have unsaturation that originated at the 2- position of an unsaturated triglyceride, usually a polyunsaturated triglyceride, they will often be rich in polyunsaturated content.
  • Fish oil (Nestle type NAD Hi EPA, 2168.7 g, 2.54 mol), ethyl acetate (6385 g, 72.5 mol), and lipase (Lipozyme® TL IM, product of Novozymes, 166.9 g) are combined and agitated at room temperature for 5 to 10 days, after which time the monoacetyl triglyceride content is less than 15%.
  • the lipase is removed by filtration, and excess ethyl acetate is stripped (45-50°C, 40 mm Hg).
  • the crude reaction mixture is combined with material from a similar run and is purified by wiped-film evaporation (2" diameter, UIC).
  • First pass conditions to remove more-volatile side products: 218°C (oil), 1.8 mm Hg.
  • the feed (4240 g) is charged over 8 h, and a bottoms stream (2780.2 g) is retained.
  • Second pass conditions 229°C (oil), 1.0 mm Hg.
  • the feed (2780.2 g) is charged over 8 h, and a bottoms stream (2101.4 g) is retained.
  • the crude reaction mixture is combined with material from a similar run and is purified by wiped-film evaporation (2" diameter, UIC).
  • Two passes both at 220°C (oil), 1.0 mm Hg, are used to remove the more-volatile by-products.
  • the feed (about 1800 g) is charged over 1.5 h for the first pass and 0.5 h for the second pass.
  • High-linoleic safflower oil 300 g, 0.343 mol, 81% linoleate content
  • 1-butanol 600 g
  • water 33 g
  • lipase Lipozyme® RM IM, product of Novozymes, 3.6 g
  • Benzaldehyde 42.0 g, 0.396 mol
  • p-TSA p-toluenesulfonic acid monohydrate
  • Soybean oil (20.0 g, 0.0229 mol), 1-octanol (82 g), water (2.2 g), and lipase (Lipozyme® RM IM, 3.6 g) are combined under nitrogen and heated to 60°C. After 5 h at 60°C, the lipase is removed by filtration. Cinnamaldehyde (4.0 g, 0.0303 mol) and p-TSA (0.25 g) are added to the filtrate, and the mixture is heated to 55°C under reduced pressure (1 to 2 mm Hg). After 3 h, potassium acetate is added to neutralize the p-TSA, and the mixture is filtered. Gas chromatography analysis of the reaction mixture shows formation of the desired 2-monoacylglyceride cinnamaldehyde acetal.
  • Menhaden oil (50.0 g, 0.0586 mol), acetonitrile (132 g), water (2.2 g, 0.122 mol), cinnamaldehyde (11.1 g, 0.102 mol), and lipase (Lipozyme® TL IM, 7.9 g) are combined under nitrogen and heated to 55°C. After 6 h at 60°C, the lipase is removed by filtration. p-Toluenesulfonic acid (0.50 g) is added to the filtrate, and the mixture is heated to 55°C under reduced pressure (100 to 10 mm Hg). After 2 h, sodium bicarbonate is added to neutralize the p-TSA, and the mixture is filtered. Gas chromatography analysis of the reaction mixture shows formation of the desired 2-monoacylglyceride cinnamaldehyde acetal.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Claims (15)

  1. Procédé, comprenant :
    (a) la réaction d'un triglycéride insaturé avec au moins deux équivalents molaires d'eau, un alcool en C1-C8, ou un mélange de ceux-ci en présence d'une lipase à une température comprise dans la plage de 20°C à 80°C pendant une période suffisante pour produire un mélange de réaction comprenant un 1,3-dihydroxy-2-monoacylglycéride et des esters ou des acides gras ;
    (b) la réaction du 1,3-dihydroxy-2-monoacylglycéride avec au moins un équivalent molaire d'un aldéhyde ou d'une cétone, en option en présence d'un catalyseur acide pour produire un mélange comprenant les esters ou les acides gras et un acétal ou cétal de 2-monoacylglycéride ; et
    (c) l'élimination des esters ou des acides gras du mélange de l'étape (b) en tant que produit de tête par distillation ou évaporation à film raclé pour isoler un acétal ou cétal de 2-monoacylglycéride purifié.
  2. Procédé selon la revendication 1, le cétal ou l'acétal de 2-monoacylglycéride isolé à l'étape (c) étant en outre purifié d'impuretés moins volatiles par distillation.
  3. Procédé selon la revendication 1 ou la revendication 2, le triglycéride insaturé étant une huile oméga-3 riche en acides gras, l'huile oméga-3 riche en acides gras comprenant de préférence des résidus d'acide gras d'acide eicosapentaénoïque (EPA), d'acide docosahexaénoïque (DHA) ou des deux.
  4. Procédé selon l'une des revendications 1 à 3, la lipase étant une lipase spécifique de position 1,3, de préférence une lipase spécifique de position 1,3 obtenue à partir d'un organisme choisi dans le groupe constitué de Candida antarctica, Candida rugosa, Thermomyces lanuginosus, Rhizopus delemar, Rhizomucor miehei, et de combinaisons de ceux-ci.
  5. Procédé selon l'une des revendications 1 à 4, l'alcool en C1-C8 étant de l'éthanol.
  6. Procédé selon l'une des revendications 1 à 5, la réaction à l'étape (a) étant réalisée à une température comprise dans la plage de 45°C à 60°C.
  7. Procédé selon l'une des revendications 1 à 6, l'aldéhyde ou la cétone étant un aldéhyde ou une cétone de qualité alimentaire, de préférence du benzaldéhyde, de la vanilline ou de l'aldéhyde cinnamique.
  8. Procédé selon l'une des revendications 1 à 7, la lipase et toute eau ou tout alcool en C1-C8 étant éliminé(e)s du mélange de réaction avant l'étape (b), et toute eau ou tout alcool en C1-C8 étant éliminé(e) à une température inférieure à 80°C.
  9. Procédé selon l'une des revendications 1 à 8, comprenant en outre la réaction de l'acétal ou du cétal de 2-monoacylglycéride purifié de l'étape (c) avec de l'eau ou un alcool en C1-C8 en présence d'une base pour produire un acide gras insaturé enrichi ou un ester alkylique en C1-C8 enrichi d'un acide gras insaturé.
  10. Procédé, comprenant :
    (a) la réaction d'un triglycéride insaturé avec au moins deux équivalents molaires d'un ester alkylique ou d'un acide carboxylique inférieur en présence d'une lipase à une température comprise dans la plage de 20°C à 80°C pendant une période suffisante pour produire un mélange de réaction comprenant un 1,3-dicarboxy-2-monoacylglycéride et des esters ou des acides gras ; et
    (b) l'élimination des esters ou des acides gras du mélange de l'étape (a) en tant que produit de tête par distillation ou évaporation à film raclé pour isoler un 1,3-dicarboxy-2-monoacylglycéride purifié.
  11. Procédé selon la revendication 10, le 1,3- dicarboxy-2-monoacylglycéride purifié isolé à l'étape (b) étant en outre purifié d'impuretés moins volatiles par distillation.
  12. Procédé selon la revendication 10 ou la revendication 11, le triglycéride insaturé étant une huile oméga-3 riche en acides gras, l'huile oméga-3 riche en acides gras comprenant de préférence des résidus d'acide gras d'acide eicosapentaénoïque (EPA), d'acide docosahexaénoïque (DHA) ou des deux.
  13. Procédé selon l'une des revendications 10 à 12, l'ester alkylique ou l'acide carboxylique inférieur étant de l'acétate d'éthyle ou de l'acide acétique, et le 1,3-dicarboxy-2-monoacylglycéride étant un 1,3-diacetoxy-2-monoacylglycéride.
  14. Procédé selon l'une des revendications 10 à 13, la lipase étant une lipase spécifique de position 1,3, de préférence une lipase spécifique de position 1,3 obtenue à partir d'un organisme choisi dans le groupe constitué de Candida antarctica, Candida rugosa, Thermomyces lanuginosus, Rhizopus delemar, Rhizomucor miehei, et de combinaisons de ceux-ci.
  15. Procédé selon l'une des revendications 10 à 14, comprenant en outre la réaction du 1,3-dicarboxy-2-monoacylglycéride purifié de l'étape (b) avec de l'eau ou un alcool en C1-C8 en présence d'une base pour produire un acide gras insaturé enrichi ou un ester alkylique en C1-C8 enrichi d'un acide gras insaturé.
EP16739318.0A 2015-07-02 2016-06-28 Procédé de préparation de 2-monoacylglycérides Active EP3317385B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562188287P 2015-07-02 2015-07-02
PCT/US2016/039728 WO2017003992A1 (fr) 2015-07-02 2016-06-28 Procédé de préparation de 2-monoacylglycérides

Publications (2)

Publication Number Publication Date
EP3317385A1 EP3317385A1 (fr) 2018-05-09
EP3317385B1 true EP3317385B1 (fr) 2019-04-03

Family

ID=56413865

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16739318.0A Active EP3317385B1 (fr) 2015-07-02 2016-06-28 Procédé de préparation de 2-monoacylglycérides

Country Status (3)

Country Link
US (1) US10961483B2 (fr)
EP (1) EP3317385B1 (fr)
WO (1) WO2017003992A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024004585A (ja) * 2022-06-29 2024-01-17 日清ファルマ株式会社 ω－３高度不飽和脂肪酸含有組成物の製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2251693A (en) 1939-03-24 1941-08-05 Procter & Gamble Preparation of monoglycerides
US2619493A (en) 1950-06-12 1952-11-25 Swift & Co Monoglycerides
US5935828A (en) 1989-05-01 1999-08-10 Opta Food Ingredients, Inc. Enzymatic production of monoglycerides containing omega-3 unsaturated fatty acids
US5116745A (en) 1990-04-19 1992-05-26 The Procter & Gamble Company Process for preparing 2-acylglycerides or 1,2-diacyl diglycerides or 2,3-diacyl diglycerides
FR2731015B1 (fr) * 1995-02-24 1997-05-30 Sci Sartone Procede d'enrichissement enzymatique d'huiles d'origine marine et les triglycerides d'acides gras polyinsatures ainsi obtenus
US5959128A (en) 1996-03-13 1999-09-28 Cargill Incorporated Method for preparation of purified glycerides and products
US7727514B2 (en) * 2005-10-03 2010-06-01 Biotechnology Research & Development Corporation Compositions comprising a UV-absorbing chromophore
EP2409695B1 (fr) * 2010-07-05 2018-03-21 Beth Israel Deaconess Medical Center, Inc. Sn-2-monoacylglycérols et malabsorption de lipide
CN103415499B (zh) 2011-03-08 2016-06-01 考格尼斯知识产权管理有限责任公司 脂肪酸酯的蒸馏方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
EP3317385A1 (fr) 2018-05-09
WO2017003992A1 (fr) 2017-01-05
US10961483B2 (en) 2021-03-30
US20180187125A1 (en) 2018-07-05

Similar Documents

Publication Publication Date Title
JP5204776B2 (ja) Ｅｐａ濃縮油およびｄｈａ濃縮油の製造方法
DK2006389T3 (en) Process for preparing concentrated polyunsaturated fatty acid oil
JP4290162B2 (ja) 対称型トリグリセリドの製造方法
CA2803477C (fr) Procede de separation des acides gras polyinsatures d'acides gras a chaine longue insatures ou moins satures
HUT76707A (en) Refining oil compositions
US20110091947A1 (en) High-Purity Purification Method for Omega-3 Highly Unsaturated Fatty Acids
JP2003500082A (ja) 蒸留−酵素的エステル交換の組合せによるポリ不飽和脂肪酸エステルの濃縮及び精製
CN113699191A (zh) 一种2-花生四烯酸甘油一酯的制备方法
JP4079516B2 (ja) トリグリセリドの製造方法
EP3317385B1 (fr) Procédé de préparation de 2-monoacylglycérides
JP3840459B2 (ja) グリセリドおよびその製造方法
JPS60234588A (ja) 長鎖高度不飽和脂肪酸アルコ−ルエステルの製造法
WO2008093378A1 (fr) Processus d'enrichissement enzymatique sélectif d'un mélange contenant des oméga trois
JP2013055893A (ja) 高度不飽和脂肪酸濃縮油の製造方法
GB2350610A (en) Preparation of pure unsaturated fatty acids
EP1749099B1 (fr) Procédé de production enzymatique de triglycérides
Nur et al. Utilization of plant lipase for glycerol monostearate synthesis
CN119816600A (zh) 用于增加植物油的sos甘油三酯含量的酶促方法
KR20190133864A (ko) 다이머산의 제조방법

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180111

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20181026

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 1115720

Country of ref document: AT

Kind code of ref document: T

Effective date: 20190415

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602016011974

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: NO

Ref legal event code: T2

Effective date: 20190403

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1115720

Country of ref document: AT

Kind code of ref document: T

Effective date: 20190403

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190803

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190704

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190703

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190803

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602016011974

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

26N No opposition filed

Effective date: 20200106

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20190630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190628

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190628

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20160628

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230609

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20250618

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20250618

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NO

Payment date: 20250624

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20250618

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20250625

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20250624

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20250701

Year of fee payment: 10